Question: How do the negative (drag) forces of myosins affect the dynamics of muscle contraction? Background: Huxley's model of muscle contraction involves the thick myosin filaments and thin actin filaments within a sarcomere sliding over one another. The relative motion of thick and thin filaments in the sarcomere is generated by the myosin heads, which undergo an actin-activated ATPase cycle, during which they form transient cross bridges between the filaments. This results in the actin filament moving a step toward the center of the sarcomere. However, the affect of individual myosin-generated drag forces on the dynamics of muscle contraction cannot be determined in muscle fiber measurements. Observations: The recent advent of studies utilizing single myosin molecules allowed Kaya and Higuchi to determine the molecular mechanism of how dragged myosins affect the dynamics of muscle contraction. They determined that step size was load dependent, whereas working size was load independent. They also found a nonlinear elasticity of myosins that was due to structural differences between the positive and negative strain directions. Indeed, they found that the stiffness of myosin was highest when the myosins were active during the working stroke and lowest when the myosins are negatively strained by the subsequent sliding of the actin filament generated by neighboring myosins. Significance: These findings suggest that, during force generation, myosins stiffen and subsequently soften to reduce drag forces on force generation by neighboring myosins. Thus the negative (drag) forces of myosins have a minimal effect on muscle contraction, and it is this nonlinear nature of myosin elasticity (i.e., softening) that underlies the high mechanical efficiency of force generation in muscles. These findings may also be applicable to other cells that move.
Question: How do the negative (drag) forces of myosins affect the dynamics of muscle contraction? Background: Huxley's model of muscle contraction involves the thick myosin filaments and thin actin filaments within a sarcomere sliding over one another. The relative motion of thick and thin filaments in the sarcomere is generated by the myosin heads, which undergo an actin-activated ATPase cycle, during which they form transient cross bridges between the filaments. This results in the actin filament moving a step toward the center of the sarcomere. However, the affect of individual myosin-generated drag forces on the dynamics of muscle contraction cannot be determined in muscle fiber measurements. Observations: The recent advent of studies utilizing single myosin molecules allowed Kaya and Higuchi to determine the molecular mechanism of how dragged myosins affect the dynamics of muscle contraction. They determined that step size was load dependent, whereas working size was load independent. They also found a nonlinear elasticity of myosins that was due to structural differences between the positive and negative strain directions. Indeed, they found that the stiffness of myosin was highest when the myosins were active during the working stroke and lowest when the myosins are negatively strained by the subsequent sliding of the actin filament generated by neighboring myosins. Significance: These findings suggest that, during force generation, myosins stiffen and subsequently soften to reduce drag forces on force generation by neighboring myosins. Thus the negative (drag) forces of myosins have a minimal effect on muscle contraction, and it is this nonlinear nature of myosin elasticity (i.e., softening) that underlies the high mechanical efficiency of force generation in muscles. These findings may also be applicable to other cells that move. Recently however, the potential utility of ketamine as an antidepressant was noted when some patients undergoing subanesthetic ketamine treatment for severe chronic pain made a significant recovery from their associated depression. The subsequent clinical studies in patients with treatment-resistant major depression confirmed that the antidepressant effects of ketamine occurred within hours of administration and persisted for days to weeks. The current report from the Duman laboratory sought to determine the underlying mechanism responsible for the fast action of ketamine on depression. Observations: Li et al. conducted an elegant series of behavioral, pharmacological, and molecular studies to elucidate a signaling pathway that could potentially mediate ketamine-induced changes in synaptic plasticity and, hence, its antidepressant effects. They determined that, in contrast to traditional antidepressants, ketamine rapidly activated the mammalian target of rapamycin (mTOR) signaling pathway, which resulted in increased levels of preand postsynaptic proteins associated with synaptogenesis in the prefrontal cortex of rats. In addition, ketamine administration increased the number and function of dendritic spines in layer V pyramidal neurons of the prefrontal cortex. Finally, ketamineinduced synaptogenesis and antidepressant effects were inhibited when mTOR signaling was pharmacologically prevented. Significance: These findings provide the first evidence that the exceptional antidepressant effects of ketamine are mediated by the mTOR signaling pathway. Indeed, in contrast to the currently available antidepressant medications, which typically require a minimum of several weeks before symptoms ameliorate, ketamine significantly and rapidly increased mTOR signaling and synaptogenesis. These findings provide hope that novel treatments targeting the mTOR pathway will become available to rapidly treat patients who are resistant to traditional medications. Question: What ubiquitin-dependent process underlies the degradation of the mutant cystic fibrosis (CF) transmembrane conductance regulator (CFTR) that has reached the plasma membrane? Background: The most common mutation associated with CF results in a loss of phenylalanine at the 508th position (⌬F508) in the CFTR apical membrane chloride channel. ⌬F508 causes misfolding, retention, and degradation of the CFTR protein via quality control (QC) mechanisms of the endoplasmic reticulum (ER). Interestingly, under certain conditions, limited amouts of ⌬F508 can escape ER-associated degradation (ERAD) and reach the plasma membrane in vitro and in vivo. However, this approach has limited therapeutic potential because the rescued (r) ⌬F508CFTR is rapidly internalized via an ubiquitin-dependent mechanism. Observations: Using functional small-interfering RNA screens in cells expressing ⌬F508 Okiyoneda et al. determined that a pair of cytosolic molecular chaperones and co-chaperones promote the degradation of defective proteins from the plasma
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Edited by Christopher D. Verrico membrane at physiological temperature. They found that r⌬F508CFTR was ubiquitinated by the CHIP ubiquitin ligase complex, rapidly internalized from the plasma membrane, and eventually degraded by lysosomal proteolysis. Additional biochemical studies determined that the r⌬F508CFTR lysosomal delivery was dependent on the endosomal sorting complex required for transport protein complexes. Significance: These findings suggest that a secondary QC mechanism maintains cellular homeostasis by eliminating defective transmembrane proteins that elude ERAD. Thus, in addition to overcoming the ER-QC mechanism, this secondary QC mechanism will need to be circumvented before this therapeutic strategy can be used for CF. Nonetheless, these findings may have relevance for understanding other disorders that are characterized by genetically or environmentally misfolded proteins as they too may be targets of this peripheral QC mechanism.
Phosphatidic acid is a pH biosensor that links membrane biogenesis to metabolism. Question: Is the synthesis of cell membranes regulated by intracellular pH? Background: Phosphatidic acid (PA) is a ubiquitous signaling lipid and a major constituent of cell membranes. In yeast, phospholipid metabolism is regulated by the transcriptional repressor protein Opi1, which is part of a lipid-sensor complex in the endoplasmic reticulum (ER). When sequestered on the ER, Opi1 binds PA. However, inositol induces the translocation of Opi1 to the nucleus, where it decreases the transcription of genes that regulate phospholipid metabolism. Because the physical and chemical properties of PA are in large part determined by the proton concentration, the authors hypothesized that intracellular pH may play an important role in regulating Opi1.
Observations: Together, the Loewen and Smits laboratories developed a novel method to accurately and quickly measure the pH in live, growing cells. Subsequently, they screened yeast for sensitivity to inositol, which yielded 231 genes that regulate phospholipid metabolism. They then found a correlation between pH and localization of Opi1 in living yeast cells. Finally, they found that PA interacted with Opi1 via a pHdependent binding mechanism, which ultimately affected genes that regulate phospholipid metabolism. Significance: Key to these findings was the development of a method sensitive enough to measure the subtle fluctuations in intracellular pH. Indeed, this allowed Young et al. to determine that very small changes in pH regulate PA, which acts as a cytosolic biosensor in yeast. Importantly, the measured range of pH corresponds to the normal variations in acidity known to exist in living yeast cells. Not only is this regulatory mechanism simple, it is also ubiquitous. Thus, given the known signaling role of PA and importance of pH regulation in human physiology, these findings may have implications for understanding pH-dependent protein-lipid interactions in all forms of life. more easily adapt and survive at high altitudes? Background: When individuals from low altitudes ascend to higher altitudes, they face several challenges related to the hypoxic conditions. In fact, lowlanders struggle to reproduce and suffer from chronic mountain sickness when they move to high altitudes. Chronic mountain sickness is thought to occur as the body attempts to compensate for the hypoxic conditions primarily by overproducing red blood cells, which contain the oxygen-carrying pigment hemoglobin. In contrast to lowlanders, Tibetan highlanders possess the unique ability to endure the stress of hypobaric hypoxia and do not develop the high concentrations of hemoglobin associated with high altitudes. This suggests that Tibetans may have evolved a blunted response to high-altitude hypoxia. Observations: Beall et al. conducted three independent studies to determine whether the hypoxic conditions associated with high altitudes acted as an agent of natural selection, resulting in the ability of Tibetan highlanders to withstand residing at high altitudes without the deleterious effects observed in lowlanders. A genome-wide allelic differentiation scan (GWADS) revealed eight single-nucleotide polymorphisms (SNPs) located near EPAS1, a member of the hypoxia-inducible factor (HIF) family of transcription factors that encodes HIF2␣. Subsequently, a candidate gene analysis of EPAS1 conducted on two independent cohorts of highlanders determined that genotype had a very large effect on phenotype; i.e., the difference in hemoglobin concentrations between the genotypes was 0.8 g/dl. Significance: The GWADS study provides evidence that suggests highlanders with SNPs near EPAS1 were naturally selected. The two independent studies that subsequently determined that the genetic variants from the GWADS study were correlated with lower hemoglobin concentrations provides further evidence of natural selection. Collectively then, these studies strongly suggest that because hypoxic conditions associated with high altitudes impairs physiological functions and survival, Tibetan highlanders evolved an adaptational mechanism to more easily function and survive at high altitudes.
Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans. Question: Is the afferent feedback from exercising muscle physiologically relevant to cardioventilatory control in humans? Background: Muscular activity evokes cardiovascular and respiratory effects via a feedforward central mechanism that concomitantly activates neural circuits associated with locomotion and autonomic discharge. In addition to this centrally mediated mechanism, there is strong evidence that thinly myelinated group III and unmyelinated group IV muscle afferents contribute to the cardiovascular and respiratory adjustments that occur during exercise. However, the relative contribution of these afferent neurons to the cardioventilatory effects associated with exercise in humans is unclear due to the difficulty of studying this phenomenon in the absence of centrally mediated affects. Observations: To assess the contribution of sensory afferents from contracting muscles to the exercise-induced cardioventilatory response, Amann et al. attenuated input from group III and IV afferents to the CNS via lumbar intrathecal administration of the opioid receptor agonist fentanyl. Fentanyl administration significantly reduced exercise-induced ventilation, heart rate, and blood pressure despite the fact that it only affected the -opioid receptor-sensitive locomotor muscle afferents. Importantly, several control experiments were conducted that allowed the authors to exclude a direct central effect of fentanyl. Significance: These well controlled findings provide strong evidence that muscle afferents are essential for regulating exercise-induced cardioventilatory responses in humans. In fact, in addition to determining that intrathecal fentanyl did not have central effects, the investigators also determined that fentanyl did not affect the feedforward component of the cardioventilatory regulation associated with skeletal muscle activation; i.e., fentanyl did not affect the magnitude of the central motor drive during intense exercise. Collectively, these studies suggest that -opioid receptor-sensitive afferent feedback from contracting muscles is a critical component in the cardiovascular and respiratory control during exercise.
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. The parathyroid glands produce parathyroid hormone (PTH), which in turn regulates calcium (Ca 2ϩ ), phosphorous (P), and vitamin D levels in the blood and bones. CKD can lead to low Ca 2ϩ levels and, hence, secondary hyperparathyroidism (SH). SH is characterized by excessive PTH production, and decreased expression of the vitamin D receptor and Ca 2ϩ -sensing receptor (CaR) in the parathyroid glands. Paricalcitol is used to treat CKD because it suppresses PTH without the calcimimetic and phosphatemic effects associated with calcitriol (a synthetic vitamin D analog). Cinacalcet, which activates CaRs, suppresses PTH, and lowers serum Ca 2ϩ and serum P levels, is used in dialysis patients (CKD stage 5). However, when cinacalcet is used in nondialysis-dependent CKD patients (stages 3-4), it increases serum P. Observations: In a rat model of stage 3-4 CKD, Finch and colleagues compared the effects of cinacalcet and paricalcitol on bone and mineral metabolism. Although both treatments suppressed PTH, only cinacalcet treatment decreased serum Ca 2ϩ and increased serum P. In addition, cinacalcet treatment caused a significant increase in urinary Ca 2ϩ excretion, which the authors suggest is due to activation of renal CaRs. Finally, cinacalcet reduced bone volume and increased bone resorption. Significance: Although the mechanism by which cinacalcet caused hypocalcemia, hyperphosphatemia, and the deleterious effects on bone requires further studies, these findings suggest that cinacalcet may have a direct negative effect in patients with stage 3-4 CKD. The observed negative effect on bone, in addition to the severe hyperphosphatemia, suggests that cinacalcet should be avoided in patients with CKD.
Cardiomyogenesis in the adult human heart. Kajstura J, Urbanek K, Perl S, Hosoda T, Zheng H, Ogórek B, Ferreira- 
Question:
What is the renewal rate of cardiomyocytes, endothelial cells, and fibroblasts in the adult human heart? Background: The ability of the adult heart to replace disease-induced loss of cardiomyocytes was only recently recognized. Indeed, scientists not only confirmed the existence of cardiac stem cells (CSCs) in adult heart myocardium, they determined that cardiac cells are constantly being replaced by CSCs. Although current estimates suggest that the renewal rate of cardiomyocytes is severalfold lower than that of endothelial cells and fibroblasts, methodological limitations could have affected the accuracy of the estimates.
Observations: Kajstura et al. used a novel approach to more precisely determine the frequency, extent, and identity of the cells that are regenerated in the adult human heart. By astutely taking advantage of the knowledge that cancer patients who receive the radiosensitizer iododeoxyuridine (IdU) as part of their treatment have IdU incorporated into the DNA of all cycling cells, which is progressively diluted in the derived progeny, they were able to measure myocyte formation over time. They found that IdU labeled cardiomyocytes, endothelial cells, and fibroblasts and subsequently calculated regeneration rates of 22%, 20%, and 13% per year, respectively. Significance: Until recently, adult cardiomyocytes were assumed to be postmitotic, and hence irreplaceable. However, the current report indicates that the human heart is not only capable of replacing its myocyte and nonmyocyte components but that the rates of replacement suggest that the entire heart could be replaced several times during the course of life.
Thus not only did this unique approach elucidate that the degree of fibroblast and endothelial cell turnover is comparable to that of cardiomyocytes, it also suggests that the rate of myocyte turnover is 4 -5 orders of magnitude higher than previously predicted. Realizing the potential of adult human hearts to regenerate will undoubtedly have important clinical implications. Background: The force response of muscle contraction that results from step-like changes in muscle length is initiated and shaped by interactions between thin myofilament proteins (actin, tropomyosin, and troponins) and thick myofilament myosins. Ultimately, the goal is to use mathematical modeling of cardiac muscle force responses based on the underlying biochemical events to better understand how these systems work, and possibly predict function, in normal and pathological states. However, historic uses of models that describe properties of striated muscle function are either too complex for routine use by experimentalists or are too simple to describe mechanistic function.
Observations: Ford and colleagues developed a simple mathematical model to evaluate the functioning of striated heart muscle. Consisting of only five parameters, the model represents the force response to step changes in muscle length. The parameters include the rate constant by which length change-induced distortion of elastic elements is dissipated, the stiffness of the muscle fiber, the amplitude of length-mediated recruitment of stiffness elements, the rate constant by which this length-mediated recruitment takes place, and the magnitude of the nonlinear interaction term by which distortion of elastic elements affects the number of recruited stiffness elements. Significance: Comprising only five parameters, this model appears to provide an excellent fit to the data and should be a useful tool for analyzing the contractile function of cardiac muscle fibers. Not only does the model provide novel insight into the contractile behavior of cardiac muscle fibers, it is also useful for characterizing the mechanistic effects that alterations of cardiac contractile proteins have on cardiac contractile function. In fact, by breaking with past mathematical models and devising a much simpler prototype to evaluate the functioning of striated heart muscle, this model should be useful for a larger field of readers. Ⅲ 
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